0 items USD 0.00Search
Your search for "global markets direct refractory acute myeloid leukemia pipeline review h2 2016" gave back 83406 results.
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Acute Myeloid Leukemia Treatment market size was valued at US$ 578.8 million in 2023. With growing demand in downstream market, the Acute...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Publisher' newest research report, the “Acute Myeloid Leukemia (AML) Biomarker Testing Industry Forecast” looks at past sales and reviews total...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
GIR
January 2023
Price: USD 3,480.00
According to our Publisher latest study, the global Acute Myeloid Leukemia (AML) Biomarker Testing market size was valued at USD million in 2022 and...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Acute Myeloid Leukemia (AML) Biomarker Testing Market The global Acute Myeloid Leukemia (AML) Biomarker Testing...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
The global Relapsed Acute Myeloid Leukemia Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global Relapsed Acute Myeloid Leukemia Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
